Skip to main content

REDINC. RED ESPAÑOLA DE LA INTERNATIONAL NUCLEOME CONSORTIUM

RED2018-102801-T

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Redes Investigación /Redes Excelencia
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

VRK1 (Y213H) homozygous mutant impairs Cajal bodies in a hereditary case of distal motor neuropathy

  • Marcos, Ana T.
  • Martín-Doncel, Elena
  • Morejón-García, Patricia
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Segura‐Puimedon, María
  • Armengol, Lluís
  • Navarro‐Pando, José M.
  • Lazo, Pedro A.
[Background]: Distal motor neuropathies with a genetic origin have a heterogeneous clinical presentation with overlapping features affecting distal nerves and including spinal muscular atrophies and amyotrophic lateral sclerosis. This indicates that their genetic background is heterogeneous., [Patient and methods]: In this work, we have identified and characterized the genetic and molecular base of a patient with a distal sensorimotor neuropathy of unknown origin. For this study, we performed whole‐exome sequencing, molecular modelling, cloning and expression of mutant gene, and biochemical and cell biology analysis of the mutant protein., [Results]: A novel homozygous recessive mutation in the human VRK1 gene, coding for a chromatin kinase, causing a substitution (c.637T > C; p.Tyr213His) in exon 8, was detected in a patient presenting since childhood a progressive distal sensorimotor neuropathy and spinal muscular atrophy syndrome, with normal intellectual development. Molecular modelling predicted this mutant VRK1 has altered the kinase activation loop by disrupting its interaction with the C‐terminal regulatory region. The p.Y213H mutant protein has a reduced kinase activity with different substrates, including histones H3 and H2AX, proteins involved in DNA damage responses, such as p53 and 53BP1, and coilin, the scaffold for Cajal bodies. The mutant VRK1(Y213H) protein is unable to rescue the formation of Cajal bodies assembled on coilin, in the absence of wild‐type VRK1., [Conclusion]: The VRK1(Y213H) mutant protein alters the activation loop, impairs the kinase activity of VRK1 causing a functional insufficiency that impairs the formation of Cajal bodies assembled on coilin, a protein that regulates SMN1 and Cajal body formation., E. M‐D., and P. M‐G. were supported by Junta de Castilla y León‐Fondo Social Europeo (ESF), and Ministerio de Educación‐FPU predoctoral (FPU16/01883) fellowships, respectively. This work was funded by grants from Ministerio de Ciencia, Innovación y Universidades‐Agencia Estatal de Investigación (SAF2016‐75744‐R, RED2018‐102801‐T) and Consejería de Educación‐Junta de Castilla y León‐ERDF (UIC‐258) to P.A.L. Ministerio de Ciencia, Innovación y Universidades‐Agencia Estatal de Investigación (RTC‐2017‐6494‐1 and RTI2018‐094434‐B‐I00) and European Commission project "CONNECT‐JPIAMR” Virtual Research Institute to P.G‐P. The Instituto de Biología Molecular y Celular del Cáncer is cofunded by Junta de Castilla y León‐European Regional Development Fund (CLC–2017–01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

VRK1 phosphorylates Tip60/KAT5 and is required for H4K16 acetylation in response to DNA damage

  • García González, Raúl
  • Morejón-García, Patricia
  • Campillo-Marcos, Ignacio
  • Salzano, Marcella
Dynamic remodeling of chromatin requires acetylation and methylation of histones, frequently affecting the same lysine residue. These alternative epigenetic modifications require the coordination of enzymes, writers and erasers, mediating them such as acetylases and deacetylases. In cells in G0/G1, DNA damage induced by doxorubicin causes an increase in histone H4K16ac, a marker of chromatin relaxation. In this context, we studied the role that VRK1, a chromatin kinase activated by DNA damage, plays in this early step. VRK1 depletion or MG149, a Tip60/KAT5 inhibitor, cause a loss of H4K16ac. DNA damage induces the phosphorylation of Tip60 mediated by VRK1 in the chromatin fraction. VRK1 directly interacts with and phosphorylates Tip60. Furthermore, the phosphorylation of Tip60 induced by doxorubicin is lost by depletion of VRK1 in both ATM +/+ and ATM−/− cells. Kinase-active VRK1, but not kinase-dead VRK1, rescues Tip60 phosphorylation induced by DNA damage independently of ATM. The Tip60 phosphorylation by VRK1 is necessary for the activating acetylation of ATM, and subsequent ATM autophosphorylation, and both are lost by VRK1 depletion. These results support that the VRK1 chromatin kinase is an upstream regulator of the initial acetylation of histones, and an early step in DNA damage responses (DDR)., This work was supported by grants from Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER [SAF2016-75744-R; RED2018-102801-T, PID2019-105610RB-I00] Consejería de Educación de la Junta de Castilla y León-ERDF [CLC-2017-01, and UIC-258] to P.A.L., R.G.-G, P.M.-G. and I.C.-M. were supported by Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo (ESF), Ministerio de Educación y Universidades [FPU 16-01883] and MINECO-FPI [BES-2014-067729] predoctoral fellowships respectively.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1

  • Monte-Serrano, Eva
  • Lazo, Pedro A.
The accessibility of DNA to different cellular functions requires a dynamic regulation of chromatin organization that is mediated by different epigenetic modifications, which regulate chromatin accessibility and degree of compaction. These epigenetic modifications, particularly the acetylation of histone H4 in lysine 14 (H4K16ac), determine the degree of chromatin accessibility to different nuclear functions, as well as to DNA damage drugs. H4K16ac is regulated by the balance between two alternative histone modifications, acetylation and deacetylation, which are mediated by acetylases and deacetylases. Tip60/KAT5 acetylates, and SIRT2 deacetylates histone H4K16. However, the balance between these two epigenetic enzymes is unknown. VRK1 regulates the level of H4K16 acetylation by activating Tip60. We have shown that the VRK1 and SIRT2 are able to form a stable protein complex. For this work, we used in vitro interaction, pull-down and in vitro kinase assays. In cells, their interaction and colocalization were detected by immunoprecipitation and immunofluorescence. The kinase activity of VRK1 is inhibited by a direct interaction of its N-terminal kinase domain with SIRT2 in vitro. This interaction causes a loss of H4K16ac similarly to the effect of a novel VRK1 inhibitor (VRK-IN-1) or VRK1 depletion. The use of specific SIRT2 inhibitors in lung adenocarcinoma cells induces H4K16ac, contrary to the novel VRK-IN-1 inhibitor, which prevents H4K16ac and a correct DNA damage response. Therefore, the inhibition of SIRT2 can cooperate with VRK1 in the accessibility of drugs to chromatin in response to DNA damage caused by doxorubicin., This research was funded by grants from Agencia Estatal de Investigación (doi: 10.13039/501100011033)–Ministerio de Ciencia e Innovación–“FEDER: Una manera de hacer Europa” (PID2019-105610RB-I00, RED2018-102801-T), Consejería de Educación de la Junta de Castilla y León–FEDER (CSI264P20, CLC-2017-01) to P.A.L. Predoctoral contract to E. M-S from Consejería de Educación–Junta de Castilla y León–Fondo Social Europeo (CSI004-18)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase

  • Monte-Serrano, Eva
  • Morejón-García, Patricia
  • Campillo-Marcos, Ignacio
  • Campos Díaz, Aurora
  • Navarro Carrasco, Elena
  • Lazo, Pedro A.
[Background]: Dynamic chromatin remodeling is associated with changes in the epigenetic pattern of histone acetylations and methylations required for processes based on dynamic chromatin remodeling and implicated in different nuclear functions. These histone epigenetic modifications need to be coordinated, a role that may be mediated by chromatin kinases such as VRK1, which phosphorylates histones H3 and H2A., [Methods]: The effect of VRK1 depletion and VRK1 inhibitor, VRK-IN-1, on the acetylation and methylation of histone H3 in K4, K9 and K27 was determined under different conditions, arrested or proliferating cells, in A549 lung adenocarcinoma and U2OS osteosarcoma cells., [Results]: Chromatin organization is determined by the phosphorylation pattern of histones mediated by different types of enzymes. We have studied how the VRK1 chromatin kinase can alter the epigenetic posttranslational modifications of histones by using siRNA, a specific inhibitor of this kinase (VRK-IN-1), and of histone acetyl and methyl transferases, as well as histone deacetylase and demethylase. Loss of VRK1 implicated a switch in the state of H3K9 posttranslational modifications. VRK1 depletion/inhibition causes a loss of H3K9 acetylation and facilitates its methylation. This effect is similar to that of the KAT inhibitor C646, and to KDM inhibitors as iadademstat (ORY-1001) or JMJD2 inhibitor. Alternatively, HDAC inhibitors (selisistat, panobinostat, vorinostat) and KMT inhibitors (tazemetostat, chaetocin) have the opposite effect of VRK1 depletion or inhibition, and cause increase of H3K9ac and a decrease of H3K9me3. VRK1 stably interacts with members of these four enzyme families. However, VRK1 can only play a role on these epigenetic modifications by indirect mechanisms in which these epigenetic enzymes are likely targets to be regulated and coordinated by VRK1., [Conclusions]: The chromatin kinase VRK1 regulates the epigenetic patterns of histone H3 acetylation and methylation in lysines 4, 9 and 27. VRK1 is a master regulator of chromatin organization associated with its specific functions, such as transcription or DNA repair., This work was supported by grants from Agencia Estatal de Investigación (https://doi.org/10.13039/501100011033) AEI/Ministerio de Ciencia e Innovación-“FEDER Una manera de hacer Europa” (PID2019-105610RB-I00, RED2018-102801-T), and Consejería de Educación de la Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01) to P. A. L. E. M.-S was funded by predoctoral contract (CSI004-18) from Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo (FSE). Ministerio de Educación-FSE predoctoral FPU contracts funded P. M.-G. (FPU16/01883) and A. C.-D. (FPU20/02978). I.C.-M. was supported by FPI-MINECO-FSE contract (BES-2014-067721). E. N-C. was funded by Agencia Estatal de Investigación-MINECO predoctoral contract (BES-2017-080543)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin

  • Navarro Carrasco, Elena
  • Campos Díaz, Aurora
  • Monte-Serrano, Eva
  • Rolfs, Frank
  • Goeij-de Haas, Richard de
  • Pham, Thang V.
  • Piersma, Sander R.
  • Jiménez, Connie R.
  • Lazo, Pedro A.
Dynamic chromatin remodeling requires regulatory mechanisms for its adaptation to different nuclear function, which are likely to be mediated by signaling proteins. In this context, VRK1 is a nuclear Ser-Thr kinase that regulates pathways associated with transcription, replication, recombination, and DNA repair. Therefore, VRK1 is a potential regulatory, or coordinator, molecule in these processes. In this work we studied the effect that VRK1 depletion has on the basal nuclear and chromatin phosphoproteome, and their associated pathways. VRK1 depletion caused an alteration in the pattern of the nuclear phosphoproteome, which is mainly associated with nucleoproteins, ribonucleoproteins, RNA splicing and processing. Next, it was determined the changes in proteins associated with DNA damage that was induced by doxorubicin treatment. Doxorubicin alters the nuclear phosphoproteome affecting proteins implicated in DDR, including DSB repair proteins NBN and 53BP1, cellular response to stress and chromatin organization proteins. In VRK1-depleted cells, the effect of doxorubicin on protein phosphorylation was reverted to basal levels. The nuclear phosphoproteome patterns induced by doxorubicin are altered by VRK1 depletion, and is enriched in histone modification proteins and chromatin associated proteins. These results indicate that VRK1 plays a major role in processes requiring chromatin remodeling in its adaptation to different biological contexts., This research was funded by grants to P. A. L. from Agencia Estatal de Investigación (https://doi.org/10.13039/501100011033-Ministerio) de Ciencia e Innovación-FEDER “Una manera de hacer Europa” (PID2019-105610RB-I00, PID2022-139598OB-I00, RED2018-102801-T), Consejería de Educación de la Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01). E. N–C was funded by Agencia Estatal de Investigación-MINECO predoctoral fellowship (BES-2017-080543) and EMBO Scientific Exchange Grant ( 9289). A. C-D was funded by a predoctoral contract from Ministerio de Universidades (FPU20/02978 ). E. M-S. was funded by a predoctoral fellowship (CSI004-18) from Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo. Cancer Center Amsterdam and Netherlands Organization for Scientific Research (NWOMiddelgroot project number 91116017) are acknowledged for support of the mass spectrometry infrastructure and Surfsara for computing infrastructure (reference e-infra180166)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy

  • Campos Díaz, Aurora
  • Morejón-García, Patricia
  • Monte-Serrano, Eva
  • Ros-Pardo, David
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Lazo, Pedro A.
Rare recessive variants in the human VRK1 gene are associated with several motor neuron diseases (MND), such as amyotrophic lateral sclerosis, spinal muscular atrophy, or distal hereditary motor neuropathies (dHMN). A case with dHMN carrying two novel VRK1 gene variants, expressing Leu200Pro (L200P) and Arg387His (R387H) variant proteins, identified that these protein variants are functionally different. The Leu200Pro variant shares with several variants in the catalytic domain the loss of the kinase activity on different substrates, such as histones, p53, or coilin. However, the distal Arg387His variant and the distal Trp375* (W375X) chinese variant, both located at the end of the low complexity C-terminal region and proximal to the termination codon, retain their catalytic activity on some substrates, and mechanistically their functional impairment is different. The L200P variant, as well as most VRK1 pathogenic variants, impairs the phosphorylation of BAF and histone H4K16 acetylation, which are required for DNA attachment to the nuclear envelope and chromatin accessibility to DNA repair mechanisms, respectively. The R387H variant impairs phosphorylation of H2AX, an early step in different types of DNA damage responses. The functional variability of VRK1 protein variants and their different combinations are a likely contributor to the clinical phenotypic heterogeneity of motor neuron and neurological diseases associated with rare VRK1 pathogenic variants., Agencia Estatal de Investigación, PID2019-105610RB-I00, Pedro A. Lazo, PID2022-139598OB-I00, Pedro A. Lazo, RED2018-102801-T, Pedro A. Lazo, RTC-2017-6494-1, Paulino Gómez-Puertas, RTI2018-094434-B-I00, Paulino Gómez-Puertas, Consejería de Educación, Junta de Castilla y León, CSI264P20, Pedro A. Lazo,CLC-2017-01, Pedro A. Lazo, CSI004-18, Eva Monte-Serrano, European JPIAMR network “EPIC-Alliance, Ministerio de Universidades, FPU20/02978, Aurora Campos-Díaz, FPU16/01883, Patricia Morejón-García., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage

  • García-González, Raúl|||0000-0003-4044-2543
  • Morejón-García, Patricia|||0000-0001-5691-5320
  • Campillo-Marcos, Ignacio|||0000-0002-7657-7127
  • Salzano, Marcella|||0000-0002-1856-8281
  • Lazo, Pedro A.|||0000-0001-8997-3025
Dynamic remodeling of chromatin requires epigenetic modifications of histones. DNA damage induced by doxorubicin causes an increase in histone H4K16ac, a marker of local chromatin relaxation. We studied the role that VRK1, a chromatin kinase activated by DNA damage, plays in this early step. VRK1 depletion or MG149, a Tip60/KAT5 inhibitor, cause a loss of H4K16ac. DNA damage induces the phosphorylation of Tip60 mediated by VRK1 in the chromatin fraction. VRK1 directly interacts and phosphorylates Tip60. This phosphorylation of Tip60 is lost by depletion of VRK1 in both ATM +/+ and ATM -/- cells. Kinase-active VRK1, but not kinase-dead VRK1, rescues Tip60 phosphorylation induced by DNA damage independently of ATM. The VRK1 chromatin kinase is an upstream regulator of the initial acetylation of histones, and an early step in DNA damage responses. Dynamic remodeling of chromatin requires acetylation and methylation of histones, frequently affecting the same lysine residue. These alternative epigenetic modifications require the coordination of enzymes, writers and erasers, mediating them such as acetylases and deacetylases. In cells in G0/G1, DNA damage induced by doxorubicin causes an increase in histone H4K16ac, a marker of chromatin relaxation. In this context, we studied the role that VRK1, a chromatin kinase activated by DNA damage, plays in this early step. VRK1 depletion or MG149, a Tip60/KAT5 inhibitor, cause a loss of H4K16ac. DNA damage induces the phosphorylation of Tip60 mediated by VRK1 in the chromatin fraction. VRK1 directly interacts with and phosphorylates Tip60. Furthermore, the phosphorylation of Tip60 induced by doxorubicin is lost by depletion of VRK1 in both ATM +/+ and ATM -/- cells. Kinase-active VRK1, but not kinase-dead VRK1, rescues Tip60 phosphorylation induced by DNA damage independently of ATM. The Tip60 phosphorylation by VRK1 is necessary for the activating acetylation of ATM, and subsequent ATM autophosphorylation, and both are lost by VRK1 depletion. These results support that the VRK1 chromatin kinase is an upstream regulator of the initial acetylation of histones, and an early step in DNA damage responses (DDR).